• ebola virus

    UTMB scientists awarded $11.3 million for new studies on Ebola virus

    Researchers at the University of Texas Medical Branch at Galveston have been awarded an $11.3 Million, multi-year grant from the National Institute of Allergy and Infectious Diseases to study immunopathogenesis of Ebola, and in particular to determine why cells infected with Ebola develop “immune system paralysis,” which inhibits immune response leads to hyper inflammation and allows the deadly infection to spread. The research will be led by Co-Principal Investigators Alexander Bukreyev, PhD., of UTMB’s Department of Pathology, and Mariano Garcia-Blanco, MD, PhD, Chair of the Biochemistry and Molecular Biology Department.

  • New study looks at long-term outcomes and costs of high-risk non-muscle invasive bladder cancer treatment

    A new research study leveraging a database from the largest equal access health system in the US, the Department of Veteran Affairs offers insight into the outcome of specific treatment patterns for advanced bladder cancer patients. Lead author Dr. Stephen Williams of the University of Texas Medical Branch says it is one of the first comprehensive studies looking at both the outcomes and the costs of treating a potentially lethal and devastating type of bladder cancer.

  • Combination Therapy Protects Against Advanced Marburg Virus Disease

    A new study conducted at the Galveston National Laboratory at The University of Texas Medical Branch at Galveston (UTMB) has shown substantial benefit to combining monoclonal antibodies and the antiviral remdesivir against advanced Marburg virus. The study was published today in Nature Communications.

  • breastfeeding mother and child

    Breast milk can be powerful, but can it stop the new coronavirus?

    There is a lot we do not know about SARS-CoV-2, the virus that causes COVID-19, including how it may interact with human milk. However, researchers at the University of Texas Medical Branch are trying to figure out if breast milk has any innate ability to stop the spread of the virus that causes COVID-19, or if an infected mother can pass antibodies to her breastfeeding child.

  • UTMB study shows spike mutation in COVID-19

    A multidisciplinary team from The University of Texas Medical Branch at Galveston has shown a dominant mutation D614G of the SARS-CoV-2 spike protein enhances viral replication in the upper respiratory airway, which may contribute to the increased transmission of COVID-19. This finding is important in understanding the evolution of SARS-CoV-2 as well as in the development of vaccines and therapeutic antibodies. The study is currently available in Nature.

  • Dr. Suresh Bhavnani banner

    Data science driven by a family need

    Dr. Suresh Bhavnani, a biomedical informatics researcher, was used to dealing with detailed medical data and spreadsheets full of numbers and complex statistics. However, when his mother fractured her hip, the anonymous numbers suddenly became personal.

  • Biological markers graphic

    Biological markers may let doctors know who gets sicker from COVID-19

    For some, COVID-19 can come and go leaving no trace and no symptoms. For others, the disease responsible for the worldwide pandemic can lead to a range of painful symptoms, a trip to an intensive care unit, and even death. How to tell who will be spared and who will be hard hit?

  • rock climbing photo

    $6.3 million grant renews UTMB's Pepper Center

    A specialized research center at The University of Texas Medical Branch at Galveston that helps older adults has received a $6.3 million renewal of its grant from the National Institute on Aging. The Claude D. Pepper Older Americans Independence Center at UTMB has been continually funded since 2000.

Categories